Genetic ablation of phospholamban results in augmented SERCA function and has been shown to augment cardiac function in muscle specific LIM protein deficient mice, a well characterized model of mammalian cardiomyopathy [3]. This evidence concerns the gene LPP and cardiomyopathy.